Statistically significant 68% (p<0.0001) proteinuria reduction compared to placebo, with reduction observed as early as Week 4 All secondary endpoints
The shallow aquifer and the water treatment plant near Sihineeru lake at Devanahalli, on the outskirts of Bengaluru. | Photo Credit: SUDHAKARA JAIN Away
NextCell Pharma AB* is proud that their drug candidate ProTrans has been highlighted in Dagens Medicin’s latest edition featuring ongoing research
NHRC, India takes suo motu cognizance of the reported death of a snake bite victim due to the delay in treatment caused by the apathy
Hair loss has emerged as a widespread concern, affecting millions across the globe. The alarming rise in hair loss patterns, particularly among younger individuals, underscores
Veteran actor Anupam Kher, who is on the promotional tour for his upcoming film ‘Signature’, recently talked about how certain parts in the movie spoke
Hamlet BioPharma – the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections – has
Orismilast Phase 2b results in atopic dermatitis (AD) presented today as a late-breaking oral presentation at the European Academy of
Sandvika, 25 September (OSE: NORCO): Norconsult Norge AS, a subsidiary of Norconsult ASA, has been selected by Stord municipality to
TOKYO, Japan & Seattle, Cambridge, Mass., United States: World’s first approved allogeneic cell therapy for corneal endothelial disease Prof. Shigeru
Socially Bharat is your comprehensive source for Social news, NGO’s, and expert insights from across India.
Copyright© 2025 Creative Bharat Powered By A Buzz Company